Search research articles
Contact Us
Filters
Showing results (131-140 of 159) with videos related to
Page
of 16
Sort By:
Cancer
|
August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)
Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
William Kevin Kelly, Susan Halabi, Michael Carducci, et al.
Future Oncology (London, England)
|
October 12, 2021
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC
Oliver Sartor, Daniel George, Bertrand Tombal, et al.
Life (Basel, Switzerland)
|
November 27, 2025
Genome-Wide Association Study for Milk Protein Content in Romanian Dual-Purpose Cattle
Daniel George Bratu, Șerban Blaga, Bianca Cornelia Zanfira, et al.
Conservation Biology : the Journal of the Society for Conservation Biology
|
July 22, 2014
Spatiotemporal patterns and risk factors for lead exposure in endangered California condors during 15 years of reintroduction
Terra R Kelly, Jesse Grantham, Daniel George, et al.
JCO Oncology Practice
|
June 17, 2021
Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell Carcinoma
Stephanie B Wheeler, Lisa P Spees, Bradford E Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2024
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)
Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov, et al.
Oncogene
|
January 20, 2022
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer
Lingfan Xu, Bing Zhao, William Butler, et al.
Urology
|
July 25, 2022
Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC)
Michaela A Dinan, Lauren E Wilson, Melissa A Greiner, et al.
Nano Letters
|
April 23, 2024
Impact of Spin-Entropy on the Thermoelectric Properties of a 2D Magnet
Alessandra Canetta, Serhii Volosheniuk, Sayooj Satheesh, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 159) with videos related to
Sort By:
Page
of 16
Cancer
|
August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)
Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
William Kevin Kelly, Susan Halabi, Michael Carducci, et al.
Future Oncology (London, England)
|
October 12, 2021
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC
Oliver Sartor, Daniel George, Bertrand Tombal, et al.
Life (Basel, Switzerland)
|
November 27, 2025
Genome-Wide Association Study for Milk Protein Content in Romanian Dual-Purpose Cattle
Daniel George Bratu, Șerban Blaga, Bianca Cornelia Zanfira, et al.
Conservation Biology : the Journal of the Society for Conservation Biology
|
July 22, 2014
Spatiotemporal patterns and risk factors for lead exposure in endangered California condors during 15 years of reintroduction
Terra R Kelly, Jesse Grantham, Daniel George, et al.
JCO Oncology Practice
|
June 17, 2021
Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell Carcinoma
Stephanie B Wheeler, Lisa P Spees, Bradford E Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2024
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)
Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov, et al.
Oncogene
|
January 20, 2022
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer
Lingfan Xu, Bing Zhao, William Butler, et al.
Urology
|
July 25, 2022
Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC)
Michaela A Dinan, Lauren E Wilson, Melissa A Greiner, et al.
Nano Letters
|
April 23, 2024
Impact of Spin-Entropy on the Thermoelectric Properties of a 2D Magnet
Alessandra Canetta, Serhii Volosheniuk, Sayooj Satheesh, et al.
Page
of 16